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SUMMARY 
Natural killer (NK) cells are a group of innate immune cells known for their ability to 
lyse target cells without prior exposure and are among the first responders in any illness. 
E26 transformation specific sequence (Ets1) is a developmentally restricted transcription factor 
found in immune tissues where it is critical for the development of lymphoid cells. Our 
laboratory and others have previously determined that Ets1 is necessary for complete NK cell 
development and function by generating an Ets1 global knockout mouse model. However, the 
Ets1 global knockout mouse model neither assesses the cell extrinsic and intrinsic functions of 
Ets1 nor does it assess Ets1 dependency at different stages of NK maturation. To address these 
concerns, we have developed and herein present a novel NK cell specific NKp46iCre mediated 
conditional deletion of Ets1 in a genetically engineered floxed Ets1 mouse model, NKp46iCre-
Ets1fl/fl. Using a comprehensive NK cell development panel for multi-color flow cytometry, a 
70% reduction of total NK cells was demonstrated in bone marrow, spleen and blood in the 
NKp46iCre -Ets1fl/fl compared to the Ets1fl/fl and the NKp46iCre controls. We further observed a 
stage specific reduction in mature NK cells in the NKp46iCre -Ets1fl/fl compared to relevant 
controls suggesting that Ets1 may be necessary for NK maturation and maintenance in addition 
to early NK cell development. Our findings not only confirm the intrinsic role of Ets1 in early 
NK cell development but also introduce a new role for Ets1 in the maintenance of the NK 
lineage as they mature to cytotoxic NK cells.   
INTRODUCTION 
1.1 Natural killer cells 
 Natural killer (NK) cells were first described over 40 years ago as large granular 
lymphocytes with the unique ability to lyse abnormal cells without prior exposure.1 Unlike B and 
T cell antigen receptors, NK cell receptors do not undergo gene rearrangement. Instead, NK cells 
go through an education process where they gain the ability to recognize the absence or decreased 
expression of self MHC class I.1 In addition to their cytotoxic abilities, NK cells have a multitude 
of roles in the immune system, including the capacity to recruit other innate immune cells through 
production of TNF, IFN and various chemokines.2 These roles make NK cells an indispensable 
part of the immune system and led to the large effort that has gone into understanding the 
intricacies of NK cell development and function. 
 Development begins in the bone marrow with the generation of NK precursors (NKP) from 
common lymphoid progenitors (CLP).3 By definition, NKPs are lineage restricted and will give 
rise to mature NK cells. These cells express IL2R (CD122) and are negative for markers of other 
hematopoietic lineages.4-6 The acquisition of NK cell specific markers, such as NK1.1 and NKp46, 
begins as NKPs give rise to immature NK cells.4 Immature NK cells lack the cytotoxic function 
of mature NK cells but represent an intermediate stage in NK cell development.4-6 They begin to 
acquire NK receptors specific for MHC class I molecules in an 
overlapping manner and go through a process of NK-cell 
licensing.5,6 After gaining functional competence in cytotoxicity and 
production of IFN, NK cells leave the bone marrow and take up 
residency in secondary lymphoid organs or peripheral blood.  
 Most commonly, surface expression of NK1.1 is used to 
identify NK cells. Subsequently, CD122+/NK1.1+ cells can be 
divided into a 4-stage process of maturation with surface density of CD27 and CD11b.7 The 
progressive upregulation of CD11b followed by downregulation of CD27 defines these stages. 
Double negative cells (stage 1) represent the least mature subset in this model and maturation 
continues in a clockwise fashion with the acquisition of CD27 and finally leading to the most 
mature cells, CD27-/CD11b+ (stage 4).7 Stage 4 in this process represents mature NK cells while 
the preceding stages are composed of intermediate immature cells. This strategy provides a means 
to track NK cell development in mice.  
1.2 Transcriptional regulation in NK cell development  
 Lineage commitment from a CLP to a NK cell is determined by a multifaceted network of 
transcription factors through both repression of alternate-cell factors and promotion NK specific 
factors.6 Several transcription factors important in early NK cell commitment cooperate to promote 
the expression of CD122 as well as to repress B and T cell gene programs. These include inhibitor 
of E protein transcription factors (Id2), Nfil3, Runx3, EOMES and T-bet.6,8 Knockout models of 
the above genes showed normal numbers of CLPs with a reduction in NKP populations.8 T-bet is 
essential for IL-15 responsiveness and continues to be important as NK cells mature by modulating 
expression of a receptor required to egress from the bone marrow.6,8 Likewise, the importance of 
Id2 in IL-15 responsiveness has been found by its ability to titrate E-protein activity.6,8 Both T-bet 
and Id2 are downstream of another transcription factor critical in early NK development, Ets1.6, 
9,10 Ets1 expression detected prior to the NKP stage and the lack of peripheral NK cells in a global 
knockout model have revealed its role in early NK cell development. 9, 10 Interestingly, Ets1 
expression in human NK cells increases significantly in immature NK cells.11 This stage specific 
increase may reflect an additional role for Ets1 in NK cell maturation in later stages.   
 In many of the above TFs, the mechanisms by which they function are poorly understood. 
Commonly, only an overall reduction in NK cell numbers has been reported which has made it 
difficult to identify when they are important. Recently, conditional knockout models have been 
used to temporally define the role of many of these factors. In the cases of Tcf1 and Nfil3, when 
the TFs were conditionally deleted in NKp46+ cells, no defects were observed, defining its 
importance in early NK cell development but not in maturation.8 This strategy has become 
increasingly central in defining mechanistic basis of observed phenotypes and continues to 
uncover more about the complex networks governing NK cell development and maturation.  
1.3 E26 transformation specific sequence (Ets1) 
Transcription factor and proto-oncogene E26 transformation specific sequence (Ets1) is 
the founding member of the Ets family of proteins.12 Ets proteins bind their DNA targets via the 
winged-helix-turn-helix Ets binding domain composed of 85 amino acids. The most common 
isoform, p54, has 8 exons and is 97% conserved between mice and humans.13 In this isoform, the 
Ets domain is encoded in the last two exons. Targets of Ets proteins are involved in a milieu of 
cellular processes including proliferation, cell cycle control and differentiation.14 For this reason, 
Ets1 overexpression leads to aberrant regulation of these cellular processes and has been 
implicated in several cancers.15 Continuing to understand how Ets1 functions is critical in 
revealing mechanisms of disease. 
Although expressed in many tissues during embryonic development, Ets1 expression 
becomes increasingly restricted to immune tissues as humans and mice age.13 An Ets1 global 
knockout murine model was previously used to establish the importance of Ets1 in lymphoid 
cells.9, 10, 16, 17 This model was developed by introducing a null mutation into both alleles of the 
murine Ets1 using homologous recombination.16 Under this model, T cells displayed proliferative 
defects and increased spontaneous apoptosis.16 Ets1 deficient B cells present a phenotype of 
increased terminally differentiated IgM plasma cells which point to Ets1 importance in B cell 
differentiation and activation.17 These data implicate Ets1 as essential for normal B and T cell 
maintenance. In contrast, both NK and NKT cells demonstrate a severe reduction in cell numbers 
in the Ets1 global knockout model.9, 10, 18 Barton et al (1998) observed a severe reduction in NK 
cells in the spleen. Ets1 deficient NK cells displayed decreased IFN- production along with 
impaired cytotoxicity to target cells.9 These results were observed again by Ramirez et al (2012) 
with an 80-90% reduction of mature NK cells in the bone marrow and spleen of Ets1 deficient 
mice. From experiments with the global Ets1 knockout murine model, three roles for the 
transcription factor Ets1 have been described: differentiation of NK cells from hematopoietic stem 
cells, expression of multiple activating NK receptors (NKRs), and regulation of cytokine 
response.10  
MATERIALS & METHODS 
Mice and genotyping 
Each mouse model was genotyped using PCR with tail snip DNA. The primers, a gift from the 
laboratory of Dr. Michael Ostrowski, for Ets1 WT (F1), Ets1 floxed (F2), and Ets1 KO (R1) have 
sequences 5’-CTCTCATTTGCCATC-TTTAGC-3’, 5’-GTTTGTTTGTTTGTTTGTTTGTTC-
3’, 5’-AACACAATATAACATCTTTTT-3’ respectively. The primers, a gift from the laboratory 
of Dr. Jianhua Yu, used to detect NKp46 iCre have sequences 5’-
CGAAATTGCCAGAATCAGAG-3’ (P1), 5’-CCTTTAGAATGCTTTGCCAA-3’ (P2), and 5’-
CTTCTGGGATCACACAACCCA-3’ (P3). Purified and sorted splenic NK cells were used to 
verify the deletion of Ets1 by iCre recombinase. NKp46 iCre mice were originally developed as 
reported in Narni-Mancielli et. al (2011). Mice used for all experiments were between 2 and 5 
months old.  
 
Cell Isolation 
Spleens and bone marrow were harvested in sterile conditions and placed in phosphate buffered 
saline (PBS) (cat. #: 14190-144). Single cell suspensions were made by passing cells through 70um 
filter. Cells were washed and re-suspended in PBS. 
 
Limited cell DNA isolation 
Sorted cells were lysed and prepared for PCR using the ARCTURUS® PicoPure® DNA 
Extraction Kit (Catalog #: KIT0103). In brief, 200 sorted cells were lysed with 12.5uL of 
PicoPure® DNA Extraction Solution for 3 hours. Standard PCR procedures were used following 
lysis. 
 
Limited cell RT-PCR analysis of Ets1 expression 
Sorted cells were lysed and prepared for cDNA generation using the Ambion Single Cell Lysis Kit 
(Catalog #: 4458235). Pre-amplification of the cDNA for 14 cycles with the following Taqman 
primers: GAPDH (ref: mm99999915_G1), NKp46 (mm01337324_G1), Ets1 (mm0117582_mH). 
The resulting pre-amplified cDNA was diluted 1:5 then subject to 40 cycles of amplification by 
PCR using primers described previously. 
 
Flow cytometric analysis 
Multi-color flow cytometry was used in phenotyping the conditional knockout model. A total of 
3e6 cells were stained with fluorochrome labeled antibodies for 30 minutes on ice then washed in 
PBS. The following antibodies were a generous gift from the laboratory of Dr. Michael Caligiuri: 
PeCy7-CD27 (LG.7F9/25-0271-82), AF647-NKp46 (29A4.1/137628). The remaining antibodies 
were purchased from BioLegend (San Diego, CA): CD45-AF700 (clone: 3D-F11/cat. #: 56-045-
82), CD19-PE (1D3/553786), CD3-PeCy5.5 (145-2C11/100328), CD122-BV510 (TM-
B1/740118), NK1.1-BV421 (PK136/562921), CD11b-FITC (M1-70/562921), Viability-APC-Cy7 
(cat. #: L34976). Cells were analyzed on a BD LSRFortessa (Franklin Lakes, NJ) or sorted with 
BD FACSAria™ Fusion (Franklin Lakes, NJ).  
Figure 1. Deletion of the Ets1 gene occurs in NK cells mediated by an NKp46 Cre promoter. (A) Breeding scheme to develop NKp46-
specific conditional knockout model. (B) In Ets1fl/fl mice, Ets-1 exons 7 and 8 are flanked by loxP. When crossed with NKp46 iCre, exons
7 and 8 are deleted via Cre-mediated recombination. (C) PCR using tail snip DNA is used to detect the Ets1fl/fl and NKp46 iCre alleles.
Lane 1 depicts an Ets1fl/WT-NKp46iCre mouse. Lanes 2-3 depict Ets1fl/fl-NKp46iCre (conditional knockout) mice.
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RESULTS 
3.1 Development of NKp46iCre-Ets1fl/fl mouse model  
  To study Ets1 dependence in maturing NK cells, we generated NKp46iCre-Ets1fl/fl mice using 
a mouse model expressing iCre recombinase under the control of the NKp46 promoter. NKp46 is 
a NK cell specific natural cytotoxicity receptor involved in forming synapses between NK cells 
and target cells.20 NK cells begin to express NKp46 as they transition from immature (i)NK cells 
to mature (m)NK cells. In this system, iCre recombinase, a site-specific DNA recombinase derived 
from bacteriophage P1, recognizes locus of X-over P (loxP) and catalyzes DNA recombination 
between loxP sites.21 When employed in a mouse, this can effectively remove a target gene in a 
tissue specific setting. In the Ets1-floxed (Ets1fl/fl) mice (kindly provided by Dr. Michael 
Ostrowski) loxP sites flank exons 7 and 8 of Ets1 (Fig. 1B). The NKp46iCre-Ets1fl/fl model was 
developed by crossing a NKp46iCre/iCre mouse with an Ets1fl/fl mouse. This resulted in a 
NKp46iCre/WT (NKp46iCre)-Ets1fl/WT mouse which was then crossed with a Ets1fl/fl mouse to get an 
NKp46iCre-Ets1fl/fl conditional knockout mouse (Fig. 1A). Genotypes were confirmed using PCR 
(Fig 1C). 
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Figure 2. Validation of NK cell-specific Ets1 deletion (A) Limited cell PCR from splenic cells of Ets1fl/fl and NKp46iCre-Ets1fl/fl (cKO)
mice. Sorted B, T, total NK, and mature (m)NK cells show cell specific 330bp conditional knockout band. (n=3) (B) 200-cell RT-PCR of
Ets1 expression across splenic cells from Ets1fl/fl, NKp46iCre and NKp46iCre-Ets1fl/fl mice. Immature (i)NK cells are CD27+/-/CD11b-).
mNK cells show significant decrease in Ets1 expression. (n=2)
 To verify that iCre-mediated recombination occurred in the crossed mice, genomic DNA was 
extracted from sorted splenic B (CD19+), T (CD3+), total NK (NK1.1+/NKp46+), and mature NK 
(CD11b+) cells (Fig 2A). PCR was used to validate that exons 7 and 8 had been removed (Fig 2A). 
The presence of the 330bp band seen in sorted NK cells and mNK cells occurs only when the 
exons are removed as a result of primer placement. Concurrently, splenic cells from Ets1 fl/fl mice 
were sorted as a control (Fig 2A). In the NKp46iCre-Ets1fl/fl mice, the Ets1 deleted allele was 
detected most abundantly in mNK (CD11b+) cells compared to the total NK cells, which had some 
of the wildtype band, and not in the B cells or T cells (Fig. 2A). In the control cells from Ets1fl/fl 
mice, no Ets1 deleted product was detected and only wildtype product was detected (Fig. 2A). 
 Additionally, we examined expression of Ets1 transcript in splenic B, T, iNK and mNK cells 
of NKp46iCre-Ets1fl/fl mice to confirm functional iCre-mediated Ets1 deletion. When normalized to 
the Ets1fl/fl control, mNK cells from NKp46iCre-Ets1fl/fl displayed a significant decrease in Ets1 
transcript expression (Fig 2B). This decrease was specific to mNK cells and was not seen in iNK 
cells which had comparable levels of Ets1 transcript to control mice. These results are consistent 
with the PCR data demonstrating NK cell specific deletion of Ets1 in NKp46iCre-Ets1fl/fl mice. 
 
 
 
 
 
 
 
 
3.2  NKp46iCre-Ets1fl/fl mice exhibit reduced CD122+ NK1.1+ cells 
  To characterize the effects of NK cell specific Ets1 deletion, lymphocyte populations from 
spleen, bone marrow and blood were analyzed using multi-color flow cytometry. Total NK cells 
(CD122+/NK1.1+) displayed a decrease in all compartments compared to control mice (Fig. 3A). 
These results are consistent with previous reports in an Ets1 global knockout mouse model.9, 10 B 
cells and T cells from NKp46iCre-Ets1fl/fl mice were unaffected by the NK specific Ets1 deletion 
(Fig. 3B). Taken together, these data further validate our model and confirm the intrinsic role of 
Ets1 in NK cell development. 
 
  
3.3  Cell intrinsic Ets1 is required for NK cell maturation 
 To determine the role of Ets1 in NK cell development, we compared the four stages of NK 
cell development from NKp46iCre-Ets1fl/fl, Ets1fl/fl, and NKp46iCre mice in both bone marrow and 
spleen. NK cells from NKp46iCre-Ets1fl/fl mice had an increased proportion of immature cells than 
those of the control mice. This was characterized by an accumulation of percent CD27+ population 
in all compartments (Fig. 3C). However, total numbers of each stage showed an overall decrease 
(Fig. 3C). Thus, Ets1 has a stage specific role in the transition of immature to mature NK cells.  
  
DISCUSSION 
 Herein we introduce a novel conditional knockout mouse model, NKp46iCre-Ets1fl/fl, and 
demonstrate that the Ets1 transcription factor has a stage-specific role in the maturation and 
maintenance of NK cells. Previous reports have described the role of Ets1 in early NK cell 
development through its regulation of ID2 and T-BET, cytokine responsiveness, and expression 
of several activating NK cell receptors.9, 10 Our report defines a new role for Ets1 in NK cell 
maturation and maintenance in a cell intrinsic, stage-specific manner.  
 Townsend et al. (2004) identified T-BET as an important factor for terminal maturation of 
NK cells in a T-BET knockout mouse model. NK cell numbers in this model were decreased in 
peripheral organs but increased in the bone marrow reflecting a developmental block in the absence 
of T-BET.22 The decrease in overall numbers of NK cells yet increased proportion of immature 
NK cells in bone marrow, and spleen in NKp46iCre-Ets1fl/fl mice may reflect defects in proliferation, 
homeostasis or survival. In a global knockout model of Zeb2, a transcription factor important in 
NK cell maturation, lack of mature NK cells was found to be a product of poor responsiveness to 
IL-15 and subsequent reduced survival.23 Interestingly, a similar phenotype was described in T 
cells of an Ets1 global knockout model.16 The T cells in this model showed increased spontaneous 
apoptosis and failure to proliferate when stimulated. This could explain the observed decrease in 
immature NK cell populations (CD27+/CD11b-) when Ets1 is knocked out, but further 
experimentation is required to distinguish such a possibility from a defect in proliferation or 
response to stimuli.  
 Likely scenarios could be hypothesized based on available data describing the consequence 
of Ets1 knockout in other models, however, the severe reduction in the size of the cell population 
under study complicates functional assays that could be performed. To explore these individual 
avenues, we intend to make use of new techniques, such as mass cytometry, that allow study of 
limited cell numbers. 
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